alpha-aminopyridine has been researched along with arsenic trioxide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bashash, D; Delshad, M; Momeny, M; Pourbagheri-Sigaroodi, A; Riyahi, N; Safaroghli-Azar, A | 1 |
Alipour, F; Bashash, D; Riyahi, N; Safaroghli-Azar, A; Sari, S; Zandi, Z | 1 |
Naoe, T | 1 |
1 review(s) available for alpha-aminopyridine and arsenic trioxide
Article | Year |
---|---|
<Editors' Choice> How to improve outcomes of elderly patients with acute myeloid leukemia: era of excitement.
Topics: Aged; Aged, 80 and over; Aminopyridines; Aniline Compounds; Antineoplastic Agents; Arsenic Trioxide; Azacitidine; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Decitabine; fms-Like Tyrosine Kinase 3; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Phenylurea Compounds; Precision Medicine; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Smoothened Receptor; Staurosporine; Sulfonamides; Survival Rate; Tretinoin; Triazines | 2020 |
2 other study(ies) available for alpha-aminopyridine and arsenic trioxide
Article | Year |
---|---|
Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: Proposing novel therapeutic potential for BKM120.
Topics: Aminopyridines; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Caspase 3; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Intracellular Space; Leukemia, Promyelocytic, Acute; Morpholines; Phosphatidylinositol 3-Kinases; Reactive Oxygen Species; Signal Transduction | 2018 |
Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO).
Topics: Aminopyridines; Anoikis; Antineoplastic Agents; Arsenic Trioxide; Cell Line; Cell Proliferation; DNA-Binding Proteins; Drug Combinations; Drug Synergism; Epithelial Cells; Female; Forkhead Transcription Factors; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Morpholines; Phosphatidylinositol 3-Kinases; Phosphatidylserines; Signal Transduction; Survivin; Telomerase; Transcription Factors | 2019 |